IHS Chemical Week

EnviroTech :: Biotech

Nitto Denko Buys Avecia Biotechnology

10:41 AM MST | February 4, 2011 | Alex Scott

Nitto Denko (Osaka, Japan), a diversified materials producer, says it has acquired Avecia Biotechnology Inc. (Milford, MA), a producer of DNA - and RNA –based medicines. Financial terms were not disclosed.   Avecia provides Good Manufacturing Practices (cGMP) services including the development of analytical methods, process validation, stability studies, quality control, and regulatory support around the production of DNA and RNA medicines.   Nitto Denko says the acquisition will enhance its activities in the nucleic medicines through a series of...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa